The best way to streamline target discovery and reduce late-stage failure is to prioritize the right target – and the best way to win the lottery is to know the winning number.

A recent study from the Wellcome-Sanger Institute and Sanofi found a common denominator between successful candidates. Therapeutic targets with clear cell type specificity in disease-relevant tissues were more likely to succeed.

Let’s put this information to work supporting more confident, efficient discovery decisions. We’ll explore curated single-cell datasets with enriched pathway, regulatory network and cell level variation data and apply them towards target discovery.

• Identify the genes expressed in your cell types
• Find patterns of biological pathway activation at cell-level resolution
• Explore curated datasets showing similar patterns of activity
• Narrow your focus to the best candidates

Register here: https://www.qiagen.com/br/knowledge-and-support/knowledge-hub/events-and-webinars/avoiding-discovery-failure-with-single-cell-data